🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective phase II clinical trial to evaluate the efficacy and ...
Status
Unknown
Location
Zhongshan City People's Hospital
Start Date
2023-06-01
Trial ID
NCT05981157
Treatments Being Tested
This study analyses the efficacy and safety of amlotinib as a study drug in...
Status
Unknown
Location
The First Affiliated Hospital of Jilin University
Start Date
2024-02-04
Trial ID
NCT06340165
Treatments Being Tested
There is currently no standard first-line treatment for stage PPGL, and the...
Status
Not Yet Recruiting
Location
Cancer Center, Sun Yat-sen University
Start Date
2025-05-01
Trial ID
NCT06429397
Treatments Being Tested
The hypothesis of this study is to discover if the capecitabine plus Anloti...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2019-04-11
Trial ID
NCT05089643
Treatments Being Tested
Evaluate the efficacy and safety of neoadjuvant furmonertinib combined with...
Status
Not Yet Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-10-01
Trial ID
NCT06585644
Treatments Being Tested
Abstract Study title: Single-center, Multi-cohort Exploratory Phase Ib/II C...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05608785
Treatments Being Tested
This is an investigator-initiated, single-arm, single-center, prospective c...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-04-29
Trial ID
NCT05747521
Treatments Being Tested
This study is a single arm, open, multi center phase II exploratory study. ...
Status
Unknown
Location
Tianjin Medical University Cancer Insititute & Hospital
Start Date
2022-09-01
Trial ID
NCT05683704
Treatments Being Tested
Study Objective: To evaluate the progression-free survival of HER-2 negativ...
Status
Unknown
Location
Cancer Center, The First Affiliated Hospital of Jilin University, Changchun, Jilin Province, China
Start Date
2024-11
Trial ID
NCT06678230
Treatments Being Tested